澳华内镜(688212.SH):实际控制人之一、董事、总经理顾小舟拟合计减持不超过260万股

Core Points - The company, Auhua Endoscopy (688212.SH), announced that its controlling shareholder, actual controller, director, and general manager, Mr. Xiao Zhoub, plans to reduce his holdings by a total of up to 2.6 million shares, which represents a maximum reduction of 1.93% of the company's total share capital [1] Summary by Category - Share Reduction Plan - Mr. Xiao plans to reduce his holdings through two methods: a centralized bidding transaction and a block trade [1] - The maximum reduction through centralized bidding is up to 1.3466 million shares, or 1.00% of the total share capital, to be executed within three months after 15 trading days from the announcement date [1] - The maximum reduction through block trade is up to 1.2534 million shares, or 0.93% of the total share capital, also to be executed within three months after 15 trading days from the announcement date [1]